112 related articles for article (PubMed ID: 17484395)
1. An identikit of patients seeking treatment for erectile dysfunction in Italy: results from the EDOS Italian database.
Fusco F; Sicuteri R; Valle D; Rossi A; Kontodimas S; Mirone V;
Arch Ital Urol Androl; 2007 Mar; 79(1):1-6. PubMed ID: 17484395
[TBL] [Abstract][Full Text] [Related]
2. Treatment-seeking behavior of erectile dysfunction patients in Europe: Results of the Erectile Dysfunction Observational Study.
Haro JM; Beardsworth A; Casariego J; Gavart S; Hatzichristou D; Martin-Morales A; Schmitt H; Mirone V; Needs N; Riley A; Varanese L; von Keitz A; Kontodimas S
J Sex Med; 2006 May; 3(3):530-40. PubMed ID: 16681479
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
[TBL] [Abstract][Full Text] [Related]
6. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
Porst H; Gacci M; Büttner H; Henneges C; Boess F
Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
[TBL] [Abstract][Full Text] [Related]
7. Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.
Sharlip ID; Shumaker BP; Hakim LS; Goldfischer E; Natanegara F; Wong DG
J Sex Med; 2008 Mar; 5(3):716-25. PubMed ID: 18304286
[TBL] [Abstract][Full Text] [Related]
8. Men with mild erectile dysfunction benefit from sildenafil treatment.
Bénard F; Carrier S; Lee JC; Talwar V; Defoy I
J Sex Med; 2010 Nov; 7(11):3725-35. PubMed ID: 20946161
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
Ortaç M; Çayan S; Çalişkan MK; Yaman MÖ; Okutucu TM; Semerci MB; Altay AB; Balbay MD; Özcan MF; Kadioğlu A
Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
[TBL] [Abstract][Full Text] [Related]
10. Sexual intercourse frequency in men presenting for treatment of erectile dysfunction: results from the pan-European erectile dysfunction observational study.
Riley A; Beardsworth A; Kontodimas S; Suarez D; Torres JV; Haro JM
J Sex Marital Ther; 2007; 33(1):3-18. PubMed ID: 17162484
[TBL] [Abstract][Full Text] [Related]
11. Long-term changes of sexual function in men with obstructive sleep apnea after initiation of continuous positive airway pressure.
Budweiser S; Luigart R; Jörres RA; Kollert F; Kleemann Y; Wieland WF; Pfeifer M; Arzt M
J Sex Med; 2013 Feb; 10(2):524-31. PubMed ID: 23088487
[TBL] [Abstract][Full Text] [Related]
12. Can the International Index of Erectile Function distinguish between organic and psychogenic erectile function?
Deveci S; O'Brien K; Ahmed A; Parker M; Guhring P; Mulhall JP
BJU Int; 2008 Aug; 102(3):354-6. PubMed ID: 18336609
[TBL] [Abstract][Full Text] [Related]
13. Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction.
Mulhall JP; Levine LA; Jünemann KP
Urology; 2006 Sep; 68(3 Suppl):17-25. PubMed ID: 17011372
[TBL] [Abstract][Full Text] [Related]
14. A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction.
El-Meliegy A; Rabah D; Al-Mitwalli K; Mostafa T; Hussein T; Istarabadi M; Lei Y; Gurbuz S
Curr Med Res Opin; 2013 Jun; 29(6):707-17. PubMed ID: 23540436
[TBL] [Abstract][Full Text] [Related]
15. Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile dysfunction.
Donatucci C; Taylor T; Thibonnier M; Bangerter K; Gittelman M; Casey R;
J Sex Med; 2004 Sep; 1(2):185-92. PubMed ID: 16422973
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and treatment satisfaction in patients with erectile dysfunction in Spain: EDOS study].
Martín-Morales A; Gutiérrez Hernández PR; Meijide Rico F; Arrondo Arrondo JL; Turbí Disla C
Actas Urol Esp; 2010 Apr; 34(4):356-64. PubMed ID: 20470698
[TBL] [Abstract][Full Text] [Related]
17. The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction.
Fisher WA; Rosen RC; Eardley I; Niederberger C; Nadel A; Kaufman J; Sand M
J Sex Med; 2004 Sep; 1(2):150-60. PubMed ID: 16422969
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).
Martin-Morales A; Haro JM; Beardsworth A; Bertsch J; Kontodimas S;
Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
Carrier S; Brock GB; Pommerville PJ; Shin J; Anglin G; Whitaker S; Beasley CM
J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827
[TBL] [Abstract][Full Text] [Related]
20. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
